ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 43 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $1 | 0.0% | 5,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $1 | -100.0% | 5,000 | -72.2% | 0.00% | -66.7% |
| Q3 2022 | $4,000 | -55.6% | 18,000 | 0.0% | 0.00% | -57.1% |
| Q2 2022 | $9,000 | -18.2% | 18,000 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $11,000 | 0.0% | 18,000 | 0.0% | 0.01% | 0.0% |
| Q4 2021 | $11,000 | -35.3% | 18,000 | 0.0% | 0.01% | -41.7% |
| Q3 2021 | $17,000 | -15.0% | 18,000 | 0.0% | 0.01% | -7.7% |
| Q2 2021 | $20,000 | +150.0% | 18,000 | +125.0% | 0.01% | +116.7% |
| Q1 2021 | $8,000 | +100.0% | 8,000 | 0.0% | 0.01% | +100.0% |
| Q4 2020 | $4,000 | +33.3% | 8,000 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $3,000 | -50.0% | 8,000 | 0.0% | 0.00% | -40.0% |
| Q4 2019 | $6,000 | +100.0% | 8,000 | +100.0% | 0.01% | +150.0% |
| Q3 2019 | $3,000 | 0.0% | 4,000 | +100.0% | 0.00% | -33.3% |
| Q2 2019 | $3,000 | -25.0% | 2,000 | 0.0% | 0.00% | -25.0% |
| Q1 2019 | $4,000 | -20.0% | 2,000 | 0.0% | 0.00% | -20.0% |
| Q4 2018 | $5,000 | -28.6% | 2,000 | 0.0% | 0.01% | -16.7% |
| Q3 2018 | $7,000 | – | 2,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greenlight Capital | 292,366 | $283,000 | 0.02% |
| Virtu Financial LLC | 204,870 | $199,000 | 0.02% |
| Verdence Capital Advisors LLC | 143,382 | $139,000 | 0.02% |
| Founders Capital Management | 18,000 | $17,000 | 0.01% |
| WOLFF WIESE MAGANA LLC | 10,740 | $10,000 | 0.01% |
| Global Strategic Investment Solutions, LLC | 23,000 | $22,000 | 0.00% |
| Belvedere Trading LLC | 118,500 | $146,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $13,000 | 0.00% |
| Atom Investors LP | 56,492 | $55,000 | 0.00% |
| Stonebridge Capital Advisors LLC | 22,000 | $21,000 | 0.00% |